Intrapleural Fibrinolytic Th erapy with Alteplase in Empyema Th oracis in Children – A prospective pilot study
Journal Title: Journal Of Pediatric Critical Care - Year 2014, Vol 1, Issue 3
Abstract
Objective: Outcome of children treated with Intrapleural alteplase therapy in empyema thoracis Design: Prospective interventional pilot study Setting: Pediatric Critical care and Pulmonology unit at Tertiary care Hospital Subjects: All patients of empyema thoracis from 1 month to 18 years of age admitted from May 2012 to April 2014. Method and intervention: Children were selected for intrapleural alteplase therapy and treated under an IRB (Institutional Review Board) approved protocol.Alteplase (4 mg) was diluted with 50 ml NS and instilled through Intercostal drain(ICD). Chest tube was kept clamped for 1 hour and then opened. The primary outcomes measured were: clinical improvement, lung expansion, ICD days and hospital stay. Secondary outcomes were 24 hour ICD output and adverse effects. Results: A total of 13 patients were given intrapleural alteplase. Median age was 3 years and ranged from 11 month to 14 years. Clinical and radiological improvement was seen in 84.6% (11/13) cases. Fever subsided within 5 days in 54% with median of 4 days (2-8days). Respiratory distress settled in median 5 days (2-7 days). ICD days were 6.63±1.8 (mean±SD) days. ICD days after starting alteplase were 3.45±1.03 (mean±SD) days. Mean hospital stay was11.27±4.14 (mean±SD) days in successful cases. Mean hospital stay including failure case was 13±5.75 (mean±SD) days.Average flow per day before alteplase was 64.5±65 ml/day which increased to 194.8±146.3 ml/day with intrapleural alteplase. (P value 0.006). Persistent fever, distress and lung collapse were seen in 15.4% (2/13) cases and both required surgical intervention. Conclusion: Intrapleural alteplase therapy in empyema is benefi cial in reducing effusion volume, clinical symptoms, hospital stay, and the need for surgical intervention.Further large trials are needed for optimum dose, duration of therapy and clamp timing for intarpleural fi bniolytic therapy as well as to defi ne relative contraindications to use of alteplase therapy.
Authors and Affiliations
Sharma PK, Saikia B, Jain P, Hussain Z, Khilnani P
Keywords
Related Articles
- EP ID EP338233
- DOI 10.21304/2014.0103.00024
- Views 52
- Downloads 0
Hemorrhagic Shock in Pediatric Trauma
Hemorrhagic shock is a preventable mortality in pediatric trauma. Assessment and management requires an understanding of the patho-physiogical processes specific to children. The key to successful management of hemorrhag...
Arterial Tortuosity Syndrome in a Neonate
Background : Arterial Tortuosity Syndrome (ATS) is a rare, autosomal recessive connective tissue disorder characterized by elongated and tortuous large and medium-sized arteries involving aorta and pulmonary arteries alo...
Acute gut injury: prevalence and impact on outcome in critically ill children.
To estimate prevalence of acute gut injury (AGI) in critically ill children during fi rst week.
A Case Of Cervicomedullary Junction Compression
The C-V junction is a transition site between mobile cranium and relatively rigid spinal column. It is also the site of the medullo-spinal junction. CV anomalies are defects of development, not necessarily congenital and...
Airway Anomalies In Paediatric Congenital Heart Diseases: Utility Of Bedside Fibreoptic Flexible Bronchoscopy
.